Dermalia
← All articles

Skin analysis for rosacea, what erythema mapping and telangiectasia findings deliver

Rosacea is a chronic, relapsing-remitting indication whose course is hard to document in words. We show how 3D skin analysis with the redness spectrum helps with erythema and telangiectasia, what role IPL and pulsed-dye laser play in the current therapy mix, and where the limits for advertising and diagnostic claims sit.

Updated 24 May 2026 · 7 min read

Rosacea is a chronic inflammatory skin disease with dominant erythema and telangiectasia (dilated superficial vessels). It comes in flares, the course over months and years is individual, and it often responds well to modern phototherapeutic procedures. 3D skin analysis with the redness spectrum provides reproducible longitudinal documentation that complements patient self-perception and clinical observation.

What the skin analysis shows in rosacea

Three findings areas are relevant for the rosacea consultation:

  • Erythema mapping: algorithmic separation of redness components from the RGB image, in mm² per region (cheeks, nose, forehead, chin). The report quantifies what is clinically often described as "diffuse redness".
  • Telangiectasia detection: cross-polarised capture reduces surface reflection and makes the fine vessel structures more visible. The software marks linear and punctate vessel structures per region.
  • Course after flares: in patients with documented flare episodes, the score progression can be reviewed against individual trigger phases (heat, alcohol, UV, stress), provided reports are produced close to the events.

Important on methodology: the software does not separate superficial erythema histologically from deeper vascular components, it is a 2D/3D imaging method, not a dermatohistological procedure. The diagnostic classification (erythematotelangiectatic, papulopustular, phymatous, ocular subtype) remains clinical.

What the skin analysis does not show

  • Rosacea subtype: the clinical subtyping (stages or phenotypes) is not derivable from the report.
  • Demodex colonisation: Demodex mites play a pathophysiological role, their quantification needs microscopy or PCR, not imaging.
  • Differential against lupus erythematosus or seborrheic dermatitis: these overlaps are resolved by history and possibly histology.
  • Ocular involvement (ocular rosacea): history and ophthalmologic evaluation, not skin analysis.

Treatment options and longitudinal documentation

Established procedures for vascular-dominant rosacea, with current literature support:

  • IPL (Intense Pulsed Light): acts through selective photothermolysis of oxyhemoglobin in superficial vessels. Meta-analyses show efficacy in reducing erythema and telangiectasia (see sources).
  • Pulsed dye laser (PDL, e.g. VBeam) at 595 nm: clinically considered the gold standard for vascular lesions. Highly selective for superficial vessels.
  • Topical therapy: brimonidine (α2 agonist, short-term erythema reduction), ivermectin (anti-inflammatory and Demodex-active), metronidazole, azelaic acid
  • Systemic therapy: low-dose modified-release doxycycline as anti-inflammatory maintenance; in severe cases low-dose isotretinoin
  • Trigger avoidance: often the most important but individual component: year-round UV protection, heat avoidance, trigger diary

Practice workflow for longitudinal documentation: baseline report before therapy, after IPL or PDL a new report about 4 to 6 weeks after each session with identical capture position. Erythema score and telangiectasia counts per region in comparison. The quantified changes belong in the record; they are not advertising material.

HWG note: advertising with before/after

Rosacea treatments with IPL or laser are covered by the advertising prohibition of § 11(1) sentence 3 No. 1 HWG following the BGH ruling of 31.07.2025 (case I ZR 170/24), as soon as the treatment falls within the scope of the HWG. Before/after images belong in the patient record and the personal consultation, not on the practice website or social media.

Practice setup for the rosacea consultation

First consultation: history (flare frequency, triggers, prior treatment, ocular symptoms), clinical inspection and subtyping, then skin analysis with the redness spectrum as baseline. The report goes to the patient as an email link. From the first follow-up the report automatically renders the comparison of erythema values per region. For long courses we recommend a fresh capture every 3 to 6 months.

Sources and further reading

As of May 2026. This article is professional information for medical practices, not a therapy recommendation in the individual case. Study citations are orientational; transferability to the individual patient remains a clinical assessment.

Related